Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, Chung-Hsin Chang, Szu-Chia Liao, Shou-Wu Lee, Yen-Chun Peng, Teng-Yu Lee, Jun-Sing Wang, Angela Quirino, José A Carrión, Nadia Marascio · 2023
Read Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients by Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, Chung-Hsin Chang, Szu-Chia Liao, Shou-Wu Lee, Yen-Chun Peng, Teng-Yu Lee, Jun-Sing Wang, Angela Quirino, José A Carrión, Nadia Marascio (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10743993.txt.
Description
Stop the liver drugs in a set kind of liver sick and the ill can flare, at times past the liver's own hold. Yi-Jie Huang and co-authors hunt the flare's marks in a 2023 chart study of two drug kinds, in sick with no scar and a mute mark kind. Half year flare counts split the drugs hard.
One drug's stops flared at near one in five; the twin's at a mere trace. Liver fail split the same way. High liver salt at the stop, a fast germ bounce in the off span, and the first drug's name each bore the flare. Age and germ bounce bore the fail. Off drug watch, the team say, must be close and long.
Catalog record
| CREATOR | Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, Chung-Hsin Chang, Szu-Chia Liao, Shou-Wu Lee, Yen-Chun Peng, Teng-Yu Lee, Jun-Sing Wang, Angela Quirino, José A Carrión, Nadia Marascio |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |